Reported by: Oahimire Omone Precious | Edited by: Oravbiere Osayomore Promise.
President Bola Ahmed Tinubu has approved the appointment of Dr Fatima Suleiman Zuntu as the new Director-General and Chief Executive Officer of the National Biosafety Management Agency (NBMA), according to a press release issued by the Office of the Secretary to the Government of the Federation on Monday, April 20, 2026. The appointment, which takes effect from April 16, 2026, is for an initial term of four years in accordance with Section 5 of the National Biosafety Management Agency Act of 2015. Dr Zuntu, a public health professional and policy strategist, has been tasked by the President to bring her expertise to bear on the agency’s mandate for the good of the nation. The announcement was signed by Chris Ugwuegbulam, Head of Information and Public Relations at the Office of the Secretary to the Government of the Federation.
The appointment comes at a critical juncture for the NBMA, the federal agency responsible for providing a regulatory framework for the safe application of modern biotechnology in Nigeria. Established in 2015, the agency has the core mandate of ensuring that the development, transfer, handling, and use of genetically modified organisms (GMOs) do not pose undue risks to human health, the environment, and biodiversity. Nigeria is one of the leading African nations actively adopting biotechnology to improve agricultural productivity, particularly through the development of pest-resistant cowpea and other genetically modified crops. However, the agency has faced persistent criticism from civil society groups and environmental advocates who argue that biosafety regulations are not always rigorously enforced. Dr Zuntu’s appointment is widely seen as an effort to strengthen public confidence in the agency’s regulatory oversight.
Dr Fatima Suleiman Zuntu brings to the position a robust background in public health and policy strategy. Although her full professional biography was not detailed in the brief press release, sources familiar with her career indicate that she has previously held senior positions in public health programmes at both state and federal levels. Her expertise spans health systems strengthening, policy design, and programme implementation, with a particular focus on integrating scientific research into governance frameworks. The President’s charge to her underscores an expectation that she will not merely administer the agency but actively drive impactful national programmes that balance innovation with safety. Her appointment also aligns with the administration’s broader emphasis on placing technocrats and professionals in leadership positions across federal agencies.
The NBMA has in recent years been at the centre of several high-profile controversies. In 2024, the agency came under fire after reports emerged that some GMO seeds were being distributed to farmers without adequate public awareness or post-release monitoring. Environmental rights groups accused the agency of being captured by biotechnology interests, while the NBMA defended its record, pointing to rigorous risk assessments and public engagement forums. More recently, the agency has been working on updating its biosafety guidelines to keep pace with rapid advances in gene editing and synthetic biology, technologies that fall outside the scope of the original 2015 Act. Dr Zuntu will be expected to steer the agency through these emerging regulatory challenges while maintaining Nigeria’s commitment to the Cartagena Protocol on Biosafety, an international treaty to which Nigeria is a signatory.
Reactions to the appointment have been cautiously optimistic. The All Farmers Association of Nigeria (AFAN) welcomed the choice of a public health professional, noting that biosafety is ultimately about protecting human health and the food supply chain. “We hope Dr Zuntu will prioritise transparency and farmer education. Many of our members still do not fully understand what GMOs are or how to handle them,” a spokesperson said. On the other hand, the Health of Mother Earth Foundation (HOMEF), a leading environmental justice group, called for the new DG to immediately publish a full inventory of all GMO products approved for commercial release in Nigeria, as well as to commission an independent health impact assessment. “The previous administration was not transparent enough. We hope Dr Zuntu will change the culture of secrecy,” HOMEF’s director said.
Dr Zuntu’s four-year term begins at a time when Nigeria is grappling with food security challenges exacerbated by climate change, population growth, and conflict in farming regions. Advocates of biotechnology argue that GMOs offer a pathway to higher yields and drought-resistant crops, while critics warn of potential long-term ecological and health consequences. The new DG will have to navigate these polarised views while ensuring that the agency’s decisions remain rooted in science and law. Her initial priorities are expected to include completing the pending revision of the biosafety regulations, strengthening the agency’s inspection and monitoring capacity, and rebuilding public trust through stakeholder engagement. President Tinubu’s administration has made food security a key pillar of its economic agenda, and the NBMA’s role in enabling or restricting biotech crops will be pivotal.
As Dr Fatima Suleiman Zuntu assumes office, the National Biosafety Management Agency enters a new chapter. The coming months will reveal whether her public health background and policy acumen can bridge the gap between innovation and safety, and between scientific promise and public apprehension. For now, the President has made his choice clear, and the task of leading Nigeria’s biosafety regulatory framework rests firmly on her shoulders.
📩 Stone Reporters News | 🌍 stonereportersnews.com
✉️ info@stonereportersnews.com | 📘 Facebook: Stone Reporters News | 🐦 X (Twitter): @StoneReportNew | 📸 Instagram: @stonereportersnews
Add comment
Comments